this version to be published. Disclosures. David M Kern is a former employee of HealthCore, Inc. Kalyani Sonawane is a former employee of HealthCore, Inc. Lawrence Chang is a former employee of Eli
A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data David M Kern,1 John J Barron,1 Bingcao Wu,1 Alex Ganetsky,2 Vincent
Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population David M Kern,1 Jill Davis,2 Setareh A Williams,3 Ozgur Tunceli,1 Bingcao
Background Inhaled corticosteroid/long-acting β2-agonist combinations (ICS/LABA) have emerged as first line therapies for chronic obstructive pulmonary disease (COPD) patients with exacerbation history. No randomized clinical trial has compared exacerbation rates among COPD patients receiving budesonide/formoterol combination (BFC) and fluticasone/salmeterol combination (FSC) to...
A US database study characterizing patients initiating a budesonide–formoterol combination versus tiotropium bromide as initial maintenance therapy for chronic obstructive pulmonary disease David M
as a result of grants or contracts, other than her salary from HealthCore. David M. Kern receives no direct compensation as a result of grants or contracts other than his salary from HealthCore
ARTICLEBackground. Individuals infected with human immunodeficiency virus (HIV) have increased risk of cardiovascular events. It is unknown whether T cell activation and senescence, 2 immunologic sequelae of HIV infection, are associated with vascular disease among HIV-infected adults. Methods. T cell phenotyping and carotid ultrasound were assessed among 115 HIV-infected women...